knowledge -WSS

knowledge

author：knowledge 2025-08-12 08:25:10 - browse：5672

Cheryl Meier had watched clinical trial enrollment announcements for years — but always for her sons’ type 1 diabetes, never for herself. Her OB-GYN had put her on Effexor for her depression 20 years ago, and it worked well enough — she could sleep for the first time in her life, and she no longer cried at every little thing. But it never worked for her dark thoughts.

But then she retired, and then she had time, and then she saw an email — “I guess once your name gets on a list, it’s there,” she said — for an experimental depression drug called zuranolone.

Unlike today’s crowded market of SSRIs, prescribed once and taken for months, years, or even indefinitely, zuranolone, developed by Sage Therapeutics, promises something different.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Adam's Biotech Scorecard: Do Sarepta's exon

knowledge

WSS

Scientists successfully use ultrasound imaging to map brain activity

ActiGraph execs on goal of drug approvals with digital endpoints

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Akili, maker of video game for ADHD, to be acquired for 34 million

Lung cancer is America's deadliest cancer. Yet so few get screened

AI used to predict Covid

knowledge

knowledge

entertainment

Hollywood unions extend contract negotiations for actors

Focused ultrasound for uterine fibroids: an uphill battle

In age of alternative facts, a scholarly course on calling out crap

An interview with Robert F. Kennedy Jr. on vaccines

Continuity nursing helped my family in our darkest PICU moments

Addiction doctors spar with methadone clinics over legislation

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

The high cost of giving birth even with insurance

Liz Cheney makes 1st public comment since Trump's election interference indictments

focus

Listen: Racing for gene therapy & a pioneering approval

Evacuations in place as 3 wildfires burn in eastern Washington state

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Dark money group runs ads on China biotech bill

Biohaven protein

First Opinion Podcast: What happens when kids become caregivers?

focus

focus

knowledge

focus